ADVIA Centaur CEA Assay

System, Test, Carcinoembryonic Antigen

Siemens Healthcare Disgnostics Inc.

The following data is part of a premarket notification filed by Siemens Healthcare Disgnostics Inc. with the FDA for Advia Centaur Cea Assay.

Pre-market Notification Details

Device IDK200215
510k NumberK200215
Device Name:ADVIA Centaur CEA Assay
ClassificationSystem, Test, Carcinoembryonic Antigen
Applicant Siemens Healthcare Disgnostics Inc. 511 Benedict Ave. Tarrytown,  NY  10591
ContactMey Lyn Vasquez
CorrespondentMey Lyn Vasquez
Siemens Healthcare Disgnostics Inc. 511 Benedict Ave. Tarrytown,  NY  10591
Product CodeDHX  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2020-01-28
Decision Date2020-04-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.